BROWNING
Toxicology of Nonenzymatic
Browning
P A Finot, Nestec, Nestle
´
Research Centre, Lausanne,
Switzerland
This article is reproduced from Encyclopaedia of Food Science,
Food Technology and Nutrition, Copyright 1993, Academic Press.
Introduction
0001 Reactions between reducing sugars and free amino
groups in foods, without any catalytic involvement of
enzymes, lead to nonenzymatic browning (Maillard
reaction) causing a reduction in nutritive value and
certain physiological and/or toxicological effects.
The browning reaction develops during both home
cooking and industrial processing of foods. Whilst
contributing to an improvement of the organoleptic
properties of foods, through aroma development,
browning is often an undesirable side-effect of obliga-
tory heat treatments applied for microbiological
(sterilization and drying) or nutritional (cooking)
reasons and for convenience (storage). Since the
Maillard reaction occurs so frequently and Maillard
reaction products are present in practically all meals,
an understanding of its biological implications is of
importance.
0002 Because of the multiplicity of the food systems, the
complexity of the chemical reactions, and the large
variety of heat treatments involved, any generaliza-
tion on the biological outcome of nonenzymatic
browning of foods is not easy. Nevertheless, a number
of studies of model amino acid/protein and sugar
reaction systems permits a classification of the bio-
logical outcome as: (1) nutritional; (2) physiological;
and (3) toxic (including genotoxic) effects.
Nutritional Effects
0003 The nutritional effects of the Maillard reaction in
foods are due both to the chemical modification of
essential nutrients which thereby become unavailable
(direct effects) and to the presence of Maillard prod-
ucts which reduce the bioavailability and disturb the
metabolism of other nutrients (indirect effect).
0004 Since it proceeds through many chemical routes
and produces a large number of chemical species, the
Maillard reaction has been divided for clarity and
convenience into two distinct stages, early and ad-
vanced, which are associated with different nutri-
tional and physiological consequences (Figure 1).
The Early Maillard Reaction
0005This first stage involves the reaction between a free
amino group and a reducing sugar to form, through
the Amadori rearrangement, a stable deoxyketose
addition compound, also called the Amadori com-
pound. This is the obligatory step for the continu-
ation of the reaction to the advanced stage.
0006At this Amadori stage, nutritional damage has
already been done. No enzyme in animal tissues
can split these complexes to regenerate the amino
compounds, which are nutritionally unavailable. In
the case of amino acids, rat growth and metabolic
studies have shown that the Amadori compounds are
biologically unavailable. Cecal and large intestinal
microorganisms in experimental animals can liberate
the complexed amino acids, but this occurs too late
in the digestive/absorptive process for a significant
in vivo utilization. The nutritional loss includes
those free amino acids and peptides that have reactive
a-amino groups, protein-bound lysine which has a
reactive e-amino group, and vitamins (thiamin,
pyridoxine, and folic acid).
0007In a model system representative of the early stage,
comprising milk powder stored at 60
C or lower for
several weeks, the most quantitatively important nu-
trient which is damaged is lysine. This is due to its high
level in milk protein compared to the other amino
compounds and of the high reactivity of its e-amino
group (Table 1). Milk is one of the most sensitive foods
to this reaction because of its high content of the redu-
cing sugar lactose in addition to lysine. The most im-
portant negative consequence of the early Maillard
reaction is therefore the ‘blockage’ of lysine in milk-
based products (infant formulae and weaning foods).
Lysine is essential for growth and its requirement is
high (103 mg kg
1
day
1
for babies as compared to
12 mg kg
1
day
1
for adults). The high, recommended
lysine level in baby formulae (minimum of 6.7 g per
100 g of protein, equal to the level in mother’s milk) is
reached using cows’ milk which contains an excess of
lysine of at least 20% compared to mother’s milk.
0008Industrially treated milks contain a certain amount
of such blocked lysine as its Amadori compound, the
amount varying between 0 and 15% depending on
the treatments applied (Table 2). Higher values are
reached with the roller drying process, though this
process is no longer used in the industrial-scale pro-
duction of milk formulae.
0009Lysine bioavailability is alsoaffectedby the Maillard
reaction in otherheat-treated foods likebread, biscuits,
and pastas, but the negative nutritional consequences
BROWNING/Toxicology of Nonenzymatic Browning 673